INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 424m ago
HOUSE PTR24m ago
SEC 13F24m ago
ROBINHOOD CHAIN24m ago
Corporate insider
BJ

Brille Brian J

Director, See RemarksCIK 0002071959

EDGAR filingsOpen in network
Disclosed transactions7
Buys / sells0 / 1
Max Insider Score55
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
27
BJ
Brille Brian JDirector, See Remarks
CAICaris Life Sciences, Inc.
Option exercise
M$976K
400.0K sh
Sep 17, 2026Sep 17, 2026
traded Sep 17, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Caris Life Sciences, Inc.Director, See Remarks · Dec 12, 2025
55
BJ
Brille Brian JDirector, See Remarks
CAICaris Life Sciences, Inc.
Open-market sale
SELL
$12.13M
400.0K sh
Sep 17, 2026
Sep 17, 2026
traded Sep 17, 2026
+0d
SEC FORM 4

Evidence

17
BJ
Brille Brian JDirector, See Remarks
CAICaris Life Sciences, Inc.
Option exercise
M—
400.0K sh
Sep 17, 2026Sep 17, 2026
traded Sep 17, 2026
+0dSEC FORM 4

Evidence

16
BJ
Brille Brian JDirector, See Remarks
CAICaris Life Sciences, Inc.
Tax withholding
F$213K
14.0K sh
May 15, 2026May 18, 2026
traded May 15, 2026
+3dSEC FORM 4

Evidence

21
BJ
Brille Brian JDirector, See Remarks
CAICaris Life Sciences, Inc.
Grant or award
A—
83.2K sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC FORM 4

Evidence

12
BJ
Brille Brian JDirector, See Remarks
CAICaris Life Sciences, Inc.
Gift
G—
650 sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC FORM 4

Evidence

12
BJ
Brille Brian JDirector, See Remarks
CAICaris Life Sciences, Inc.
Gift
G—
650 sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC FORM 4

Evidence